MSMR
Exchange-traded product on NYSE (US)
- Type
- Exchange-traded product
- Share class
- —
- Status
- listed
- ISIN
- —
- Currency
- —
- Represents the company
- No
Holdings as of Jul 31, 2026
The full portfolio as of the quarter end Jul 31, 2026, from the fund's report to the SEC (Form N-PORT, filed Sep 29, 2026), the newest we have: we do not read a daily file from this fund's website, or the filing is newer. Every line is listed: holdings we could identify link to their page, the rest (bonds, CLOs, loans, derivatives, securities we do not carry) are shown as filed, debt with its coupon and maturity; Shares is the principal amount for debt. Short positions are negative. Change is the share count against the filing of Apr 30, 2026.
5 lines, 4 linked, weights sum to 100.07% · Actively managed (N-CEN)
| Holding | Ticker / identifier | Type | Shares | Change | Weight | Market value |
|---|---|---|---|---|---|---|
| iShares 0-3 Month Treasury Bon | SGOV US46436E7186 | Fund | 714,678 | new +714,678 | 39.45% | $ 71.975M |
|
First American Treasury Obliga
|
FXFXX US31846V3289 | Money market | 36,485,925.11 | +35,154,093.3 | 20.00% | $ 36.486M |
| iShares U.S. Pharmaceuticals E | IHE US4642888360 | Fund | 279,847 | new +279,847 | 15.59% | $ 28.438M |
| iShares Russell 2000 ETF | IWM US4642876555 | Fund | 93,924 | new +93,924 | 14.99% | $ 27.351M |
| SPDR Gold MiniShares Trust | GLDM US98149E3036 | Fund | 228,485 | new +228,485 | 10.04% | $ 18.311M |